Trial Profile

The effect of food on the pharmacokinetics, tolerability and pharmacodynamics of BNC210 in healthy male volunteers.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 08 Jun 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs BNC 210 (Primary)
Indications Anxiety disorders
Focus Adverse reactions; Biomarker; Pharmacokinetics

Most Recent Events

08 Jul 2011 Actual initiation date (5 May 2010) added as reported by Australian New Zealand Clinical Trials Registry.
08 Jul 2011 New source identified and integrated (Australian New Zealand Clinical Trials Registry; ACTRN12610000442000).
21 Jun 2010 Status changed from planning to completed, according to a Bionomics media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com